US Patent Issued to Jiangsu Yahong Meditech, Asieris Pharmaceuticals (Shanghai) on March 24 for "Crystal form of nitroxoline prodrug, pharmaceutical composition containing same, and preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,835, issued on March 24, was assigned to Jiangsu Yahong Meditech Co. Ltd. (Taizhou Jiangsu, China) and Asieris Pharmaceuticals (Shanghai) Co. Ltd. (Shanghai).

"Crystal form of nitroxoline prodrug, pharmaceutical composition containing same, and preparation method therefor and application thereof" was invented by Liang Wu (Taizhou, China), Chen Zhou (Taizhou, China) and Yijun Deng (Taizhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a crystal form of a nitroxoline prodrug, a pharmaceutical composition containing same, and a preparation method therefor and an application thereof. An X-ray powder diffraction ...